Clinical Trial Update: A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures [Phase 3]

View source ↗

Summary

A Phase 3 double-blind trial evaluating brivaracetam as monotherapy in adults with partial-onset seizures was terminated, with results posted in January 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• BRIVARACETAM (brivaracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 3 | Status: TERMINATED | Results posted: 2017-01-18